The global epidemic of diabetes is one of the most serious problems that human beings have ever met. The IDF Diabetes Atlas describes 285 millions live with diabetes in 2010 globally, and the number will rise to 438 million by 2030. The region with the highest number is, and will remain to be, Southeast Asia, where 59 millions suffer from the disease. Even worse for our area is the perplexing fact that the number of diabetes in Asia is progressing much more rapidly than in other parts of the world. In addition, the phenotype of Asian diabetes (i.e. non-obese and insulin secretory dysfunction) generally differs from that in other ethnicities (i.e. obese and insulin resistance), and existence of such ethnic differences requires research specific to Asian diabetes to improve diabetes care in our region. There are, thus, strong demands for ting up diabetes-related healthcare professionals and scientists in Asia to fight against diabetes.
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It is said that the number of Japan project of the international cooperation in health and medical sector in Asian countries increased after the humanitarian assistance for Cambodian refugee camp that had happened in 1979. In 1990's, Japanese assistance in health sector changed from the research cooperation such as the tropical diseases to humanitarian assistance and public health issues such as infectious disease, International medical center of Japan (IMCJ), MOH, started its international cooperation in 1986 when its department of international cooperation was established in order to promote international cooperation.
Afterwards, the public health project and the mother and child health project became main issues rather than hospital related issues. IMCJ started its projects in Thailand, Laos, Chine and Cambodia focus on infectious diseases such as polio and mother and child health issues.
In 21st century, the non communicable disease such as high blood pressure, the diabetic and cardiac infarction was becoming significant issues even in developing countries. It comes to be said as a double burden in developing countries.
The diabetic mellitus in Asia would become a big issue in the future. Japan should cooperate with the specialist in countries of Asia in order to find out the solution for the diabetic patients in the developing country where no enough resources are available.
I hope that the member of this academic society will promotes the cooperation activities regarding to Diabetes Mellitus in Asia and could solve several issues in the future together. 
